LUGPA 2019 VL

Transrectal vs Transperineal - Matthew Allaway

Details
Matthew Allaway, CEO of Corbin Clinical Resources, surveys the relative benefits of transperineal versus transrectal prostate biopsy. Although transrectal ultrasound-guided prostate biopsy has been the standard for prostate cancer diagnosis since the 1980s, recent studies have revisited the transperineal approach due to the incidence of infectious and sepsis complications and missed cancer diagnos...

Advanced Prostate Cancer Clinic: What’s Changing? - Maha Hussain

Details
Maha Hussain highlights the pearls in the treatment landscape of metastatic hormone-sensitive, castration-resistant, and non-metastatic castration-resistant disease that came out of the last few years in prostate cancer in terms of the evolution of therapeutics. She details a plethora of clinical trials that had led to significant clinical benefit for patients, primarily overall survival advantage...

Advanced Bladder Cancer Clinic: Are you Ready? - Neal Shore

Details
In this 2019 LUGPA CME presentation by Neal Shore, he makes the case that now is the time to be developing your advanced bladder cancer clinics. There has been a tremendous amount of advancement in frontline metastatic bladder cancer and Neal Shore highlights some of the rapid changes in the field of both metastatic locally advanced and high-risk bladder cancer. PD receptor blockers, FGFR-targetin...

Incontinence Options for Men and Women: Is It Safe? - Eric S. Rovner

Details
In this presentation, Eric Rovner highlights the incontinence options for women and men, focusing primarily on mesh. Is mesh safe in men with stress incontinence? Is mesh safe for women? Why do some patients have complications with mesh? Are the surgeons to blame or is it the mesh itself? Dr. Rovner helps break down these questions in this LUGPA 2019 CME presentation. Biographies: Eric S. Rovner,...

UTI – Is Traditional Culture Testing Obsolete? - Edward Schaeffer

Details
In urology, urinary tract infections are categorized into two main categories. Those with uncomplicated and those with complicated infections. Patients who have uncomplicated infections are young women premenopausal, not pregnant, and they have limited comorbidities. The symptoms that we associate with an uncomplicated infection are predominantly lower urinary tract urgency, dysuria, blood in the...

Genomic Testing - Profiling for Optimization in Cancer Care - Brian T. Helfand

Details
Brian Helfand presents the use of genomics today to personalize the treatment of men with prostate cancer and the different models on how to implement this testing in your clinic. There are not enough genetic counselors throughout the country to answer everyone's needs, so it is important as a urologist to start initiating these conversations with patients. Biographies: Brian T. Helfand, M.D., Ph....

Radiation Therapy Advances and Technology Overview - Daniel Spratt

Details
Daniel Spratt presents on practical aspects of the technological evolution in radiation therapy during the 2019 LUGPA CME session. He focuses his presentation on technological advances in radiation therapy including a hybrid of software and hardware, which is the technology of our ability to plan radiation therapy going from a 2D to 3D to IMRT era, imaging tumors when you put a patient on a machin...

Urine is Not Sterile: What the Urobiome Means for Pelvic Floor Surgeons - Alan J. Wolfe

Details
Alan Wolfe disputes the old dogma that the bladder is sterile. He explains that there are bacteria that normally live in healthy bladders called the urinary microbiota or urinary microbiome and gets into much more detail in this 2019 LUGPA CME presentation. Biography: Alan J. Wolfe, PhD, Department of Microbiology and Immunology, Loyola University Chicago, Chicago, Illinois, USA. Related Content:...

CT Guided Percutaneous Renal Mass Cryoablation - Daniel Watson

Details
Daniel Watson and Alan Burns present their collaborative approach in favor of percutaneous renal mass cryoablation for renal masses. To date, Dr. Watson and Burns have done 207 of these procedures. The mean age of the patient is approximately 69 years and the mean size of the lesions is about 2.3 centimeters. Dr. Watson suggests a 85% cure rate with this procedure. Biographies: Daniel L. Watson, M...

Supine PCNL (Ambulatory): Who? What? When? Why? How? - James F. Borin

Details
James Borin speaks about the revolution and the evolution of percutaneous renal surgery. The evolution of the technique is now using ultrasound guidance and smaller scopes, mini-percs with endoscopic guidance. Dr. Borin answers the following questions during his presentation: who can have a supine PCNL? What is it?, and When should it be done ambulatory? He also describes what he calls a hybrid pr...